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1. Introduction 
Alkyl and arylboronic acids are potent competitive 
inhibitors of serine proteases [l-S]. These compounds 
have been known to inhibit hydrolytic enzymes at 
least since Torssel showed that benzeneboronic acids 
are potent inhibitors of serum cholinesterase [6]. 
Crystal structure determinations [7], NMR studies 
[8], and laser Raman studies [9] have helped to deter- 
mine the structure of the enzyme-inhibitor complex, 
while rapid kinetic studies have helped to elucidate 
the mechanism of association [lo]. 
Here, we report dissociation constants for a num- 
ber of different boronic acid inhibitors of the bacte- 
rial protease subtilisin Novo (EC 3.4.2 1 .14). One of 
these, Ndansyl-3aminobenzeneboronic acid (or 
N-(5 dimethylamino-1 -naphthalenesulfonyl)-3-amino- 
benzeneboronic acid, abbreviated as Dns-BBA) is a 
fluorescent boronic acid first prepared in [ 111, for use 
in cytological experiments as a carbohydrate ligand. 
We find that the introduction of the dansyl group 
makes this compound the most potent boronic acid 
serine protease inhibitor yet found. This inhibitor 
also exhibits a significant increase in fluorescence 
intensity upon binding. 
We also report binding constants for a variety of 
other newly studied arylboronic acids. Halogenated 
benzeneboronic acids are good subtilisin inhibitors, 
with dissociation constants <lo-’ M. 
2. Materials and methods 
Lyophilized subtilisin Novo was a gift of Novo 
Pharmaceuticals (Wilton CT). Its concentration was 
determined by use of a second-order rate assay using 
4nitrophenylbutyrate [ 121. The concentration of 
subtilisin solutions after passage on Sephadex G-25 
was determined by using the extinction coefficient in 
[ 13].4-Nitrophenylbutyrate was purchased from 
Sigma. Dns-BBA was purchased from Aldrich. 4-Tolu- 
eneboronic acid was prepared as in [ 141. 3Succinyl- 
amidobenzeneboronic acid was prepared as in [1.5]. 
3,5-Bis(trifluoromethyl)benzeneboronic acid and 
2,4dichlorobenzeneboronic acid were purchased from 
Alfa/Ventron. 1 -Naphthaleneboronic acid was pur- 
chased from Bader/Aldrich. R-l -Acetamido-2-phenyl- 
ethaneboronic acid [ 161 was a gift of Professor D. S. 
Matteson. Subtilisin kinetics were observed spectro- 
photometrically using 4nitrophenylbutyrate as a sub- 
strate in 0.1 M ionic strength buffers at 25°C [ 121. 
Substrate hydrolyses were observed in a Schoeffel/ 
McPherson spectrophotometer. Fluorescence studies 
were done using a Hitachi/Perkin-Elmer MPF3A spec- 
trofluorimeter. The spectra were observed in 0.1 M 
ionic strength buffers at 27’C and were corrected for 
background emission. For enzymatic reactions, buffers 
used were phosphate (pH S-8), ammonia (pH 8-9) 
and bicarbonate (pH 9-l 0) [ 171. 
3. Results and discussion 
3 .l . Effect of structure on inhibitor binding constants 
Table 1 shows dissociation constants for the bind- 
ing of various arylboronic acids to subtilisin. These 
data were collected at pH 7.0. Since pK, (see below) 
for various arylboronic acids is usually near 7 [2], it 
might be expected that the limiting value for these 
constants is -l/2 that shown here. 
The data in table 1 are consistent with observations 
showing that electron-withdrawing groups enhance 
the affinity of boronic acids to subtilisin [2,18]. Such 
an explanation most reasonably accounts for the very 
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Table 1 
Boronic acid inhibition constants at pH 7.0 
Inhibitor Ki (M) 
N-Dansyl-3aminobenzeneboronic acid 1.8 x 1O-6 
R-1-Acetamido-2-phenylethaneboronic a id 4.0 x lo+ 
3,5 -Bis-(Trifluoromethyl)-benzeneboronic a id 5.3 x 1o-6 
2,4-Dichlorobenzeneboronic a id 9.4 x 1o-6 
1-Naphthaleneboronic acid 4.5 x 1o-5 
36uccinylamidobenzeneboronic acid 2.2 x 1o-4 
4-Tolueneboronic acid 4.5 x 1o-4 
good affinity of the fluorine- and chlorine-substituted 
boronic acids listed here. The electron-withdrawing 
halide side chain groups are unlikely to fit into any 
substrate binding site, yet they clearly do enhance 
binding affinity. In contrast, the methyl group in 
4-tolueneboronic acid does not greatly enhance the 
affinity of this compound to subtilisin, when com- 
pared to the parent benzeneboronic acid [2]. How- 
ever, the sterically similar 4-bromobenzeneboronic 
acid [2] is a much better inhibitor, presumably 
because of electronic reasons. 
Since these Ki-values are not limiting values, and 
since pK r-values have been observed to vary some- 
what, it is not appropriate to calculate a Hammett 
p-value from these data. However, the data in table 1, 
when taken with published values, are consistent with 
the p = 2.7 in [ 181. This p is similar to that shown on 
ionization of boronic acids, and is presumably due to 
the similarity between the tetrahedral form of the 
bound inhibitor (fig.1) [79] and the tetrahedral form 
of the ionized inhibitor [20]. 
Dns-BBA, with a Ki of 1.8 X 1 0m6 M at pH 7, 
clearly deviates from the pattern shown in table 1, 
since its side chain group would be expected to have 
an electronic effect similar to that of 3succinylamido- 
benzeneboronic acid. The enhanced binding ability of 
Dns-BBA may be due to either some specific binding 
effect brought about by the Dns group in the mefa- 
OH 
R-k-OH 
Fig.1. Configuration of boronic acid inhibitors in the active 
site of serine proteases [71. 
position, or it may be due to the effects of increased 
inhibitor hydrophobicity on Ki. This last suggestion is 
supported to some degree by the fact that 1 naphtha- 
leneboronic acid has a Ki 4.5-fold better than that of 
benzeneboronic acid at this pH [2]. Since Dns-BBA 
has both the naphthalene and benzene rings, its tighter 
binding might be expected simply on the basis of 
hydrophobicity alone [21]. However, we think that 
this is unlikely to be the only explanation for the 
tight binding shown by Dns-BBA. We are continuing 
studies on protease inhibition by this reagent. 
The binding constant for the second compound 
listed in table 1, an analogue of N-acetyl-L-phenylala- 
nine, shows that binding constants of substituted ben- 
zeneboronic acids are similar to that for a compound 
that was prepared in order to resemble as closely as 
possible the transition state in the enzymatic reac- 
tion. However, this amino acid analogue (prepared by 
Matteson and coworkers [ 161) has a valuable potential 
for further elaboration into more specific inhibitors. 
The binding constant reported here is similar to that 
found for chymotrypsin [ 161. 
3.2. pH Dependence of binding 
Fig.2 shows the pH profile for the binding of Dns- 
BBA to subtilisin. As has been observed for other 
boronic acids [2], inhibition is dependent on two pK 
values, one always near 7.2, and the other at various 
points above this. The first pK is identical to the pK 
observed in acylation reactions using specific or non- 
specific substrates. The second pK has been observed 
to vary with the boronic acid used. Unlike chymo- 
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Fig.2. pH profile for the inhibition of subtiiisin by Dns-BBA. 
The theoretical curve corresponds to pK, = 7.2, pK, = 7.8, and 
Ki (lim) = 7 x lo-’ M. Reaction conditions are described in 
section 2. 
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Fig.3. Fluorescence emission of Dns-BBA: In the presence of 
subtilisin at pH 7.8 (*), in the absence of subtilisin at pH 7.8 
(A), and in the absence of subtilisin at pH 9.2 (+). Subtilisin is 
3.5 X lo-* M and the Dns-BBA is 1.2 X 10e5 M. The ordinate 
is labeled with arbitrary units proportional to the intensity of 
fluorescence. Conditions are given in section 2. 
trypsin, subtilisin exhibits no pH-dependent variations 
in binding constants for neutral ligands over pH 4-l 0 
[12,22,23]. The pH profile shown in fig.2 supports 
the observation [2] that it is the neutral, trigonal 
boronic acids that bind to the alkaline form of the 
enzyme active site. 
3.3. Inhibitor fluorescence 
Fig.3 shows that the fluorescence emission of Dns- 
BBA is markedly enhanced by binding to subtilisin. 
This enhancement is greater than that seen on ioniza- 
tion of the inhibitor. We thank that this fluorescence 
enhancement may be useful in studying the mecha- 
nism of boronic acid-enzyme interactions. Ultrastruc- 
tural studies using Dns-BBA may reveal the location 
of not only certain carbohydrates, but also the loca- 
tion of serine proteases. Since the affinity constants 
of Dns-BBAto carbohydrates have not been measured, 
it is unclear which effect is predominant in cytological 
studies [ 111. 
We attempted to observe the fluorescence emission 
of 1 -naphthaleneboronic acid when bound to subtili- 
sin. However, a high subtilisin concentration is needed 
to bind a significant proportion of the inhibitor, as 
b&ding is weaker than that for Dns-BBA. Since the 
excitation maximum for 1 -naphthaleneboronic acid 
overlaps significantly with the absorbance maximum 
of the enzyme, the high enzyme concentration made 
it difficult to reliably observe inhibitor fluorescence. 
We are continuing to study the fluorescence 
[lOI 
1111 
(121 
I131 
[I41 
I151 
[I61 
[I71 
1181 
1191 
[201 
1211 
WI 
~31 
[9] Hess, G. P., Seybert, D., Lewis, A., Spoonhower, J. and 
Cookingham, R. (1975) Science 189, 384-386. 
Nakatani,H., Uehara, Y. and Hiromi,K. (1975) J. Bio- 
them. 78,611-616. 
Burnett, T. J., Peebles, H. C. and Hageman, J. H. (1980) 
Biochem. Biophys. Res. Commun. 96, 157-162. 
Philipp, M., Tsai, I.-H. and Bender, M. L. (1979) Bio- 
chemistry 18, 3769-3773. 
Matsubara, H., Kaspar, C. B., Brown, D. M. and Smith, 
E. L. (1965) J. Biol. Chem. 240, 1125-1130. 
Bean, F. R. and Johnson, J. R. (1932) J. Am. Chem. 
Sot. 51,4415-4425. 
Weith, H. L., Wiebers, J. L. and Gilham, P. T. (1970) 
Biochemistry 9,4396-4401. 
Matteson, D. S., Sadhu, K. M. and Lienhard, G. E. 
(1981) J. Am. Chem. Sot. in press. 
Long, C. (1961) in: Biochemists Handbook, pp. 30-42, 
Van Nostrand, Princeton NJ. 
Nakatani, H., Morita, T. and Hiromi, K. (1978) Biochim. 
Biophys. Acta 525,423-428. 
Jaffe, H. H. (1953) Chem. Rev. 53, 191-261. 
Lorand, J. P. and Edwards, J. 0. (1959) J. Org. Chem. 
24,169-774. 
Wildnauer, R. and Canady, W. J. (1966) Biochemistry 5,
2885-2892. 
Morihara, K., Oka, T. and Tsuzuki, H. (1970) Arch. Bio- 
them. Biophys. 138,515-525. 
Polgi, L. and Bender, M. L. (1967) Biochemistry 6, 
610-620. 
enhancement seen upon binding of Dns-BBA to sub- 
tilisin. 
Acknowledgements 
This work was supported by a grant from the Mus- 
cular Dystrophy Association. We would also like to 
thank Professor D. S. Matteson for the gift of R-acet- 
amido-2-phenylethaneboronic acid, and Mr Roger 
Tietze for preparing the 4-tolueneboronic acid. 
References 
[ 1 ] Antonov, V. K., Ivaniva, T. V., Berezin, 1. V. and 
Martinek, K. (1971) FEBS Lett. 7, 23-25. 
[2] Philipp, M. and Bender, M. L. (1971) Proc. Natl. Acad. 
Sci. USA 68,478-480. 
[3] Koehler, K. A. and Lienhard, G. E. (1971) Biochemistry 
10, 2477-2483. 
[4] Rawn, J. D. and Lienhard, G. E. (1974) Biochemistry 
13, 3124-3130. 
[5] Lindquist, R. N. and Terry,C. (1974) Arch. Biochem. 
Biophys. 160, 135-144. 
[6] Torssel, K. (1957) Arkiv Kemi 10, 529-540. 
(71 Matthews, D. A., Alden, R. A., Birktoft, J. J., Freer, 
S. T. and Kraut, J. (1975) J. Biol. Chem. 250, 
7120-7126. 
[ 81 Robillard, G. and Schulman, R. G. (1974) J. Mol. Biol. 
86, 541-558. 
38 
